Halma completed the acquisition of Lamidey Noury Medical for €50m.

Halma, a global group of life-saving technology companies, completed the acquisition of Lamidey Noury Medical, a provider of advanced electrosurgical and associated energy devices which are used in minimally invasive urology, gynaecology, and general surgery, for €50m. "Lamidey Noury is an exciting acquisition which will bring new minimally invasive surgical product capabilities to our Healthcare Sector. Its advanced products improve patient outcomes and the efficiency of healthcare providers in treating the increasing incidence of urological and gynaecological disease. It is adjacent to our existing presence in diagnosis and biopsy devices for these diseases through Rovers Medical Devices and IZI Medical. We are delighted to welcome Lamidey Noury to Halma and look forward to supporting its development as it continues to scale its business globally," Marc Ronchetti, Halma CEO.